New User Account Set Up

If you do not have an account with the Digest, please click on "Submit to the Digest." By logging in with your UCLA Login ID (formerly known as BOL Login), a new account will automatically be generated. If you experience any difficulties, please send an email to our help desk: drc-support@ctrl.ucla.edu.

Questions

If you have any questions or concerns, please email our help desk/support team: drc-support@ctrl.ucla.edu. We are more than happy to address any questions or concerns regarding the Weekly Message Digest system you may have.

How do I subscribe?

If you have a mednet email account (@mednet.ucla.edu), you should already be subscribed.

If you do not have a mednet email account or you are not receiving the Digest, please send an email to drc-support@ctrl.ucla.edu and we will add you to our list.

SPORE-JCCC GU Oncology Seminar: "Prostate Cancer - A Molecular Pathology Approach" - Michael C. Haffner, MD, PhD

Title: SPORE-JCCC GU Oncology Seminar: "Prostate Cancer - A Molecular Pathology Approach" - Michael C. Haffner, MD, PhD
Date & Time: Feb 27, 2018 12:00 PM - 1:00 PM
Location: CHS 53-105

 

UCLA SPORE in Prostate Cancer and the UCLA JCCC present Michael C. Haffner, MD, PhD

Michael C. Haffner, MD, PhD will be presenting on "Prostate Cancer - A Molecular Pathology Approach". 

Dr. Haffner has received his M.D. and Ph.D. from the University of Innsbruck, Austria. He continued his postdoctoral training at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in the laboratory of Dr. William Nelson before transitioning to his clinical training in Anatomic Pathology at Johns Hopkins.

His research focuses on multiple aspects of prostate cancer biology and pathology. He has developed and co-developed several methods for genome wide investigation of DNA methylation changes and has carried out a number of studies dissecting the intra-tumor heterogeneity and clonal evolution of solid tumors using integrated approaches of cutting edge molecular biology and pathology. In addition, Dr. Haffner has lead discovery efforts elucidating novel mechanisms of nuclear hormone signaling that provided first evidence that activation of the androgen receptor can result in DNA damage. This observation has led to the identification of factors involved in the generation of recurrent gene fusions in prostate cancer.

 

The lecture will be held in 53-105 CHS on Tuesday, February 27, 2018 from noon to 1pm.

 

Light lunch will be served. Attendance does not require an RSVP.

Posting Information
This posting expired on February 28, 2018.
Posting Attachment: Download Attachment

Share this posting on social media!